News Releases
The latest company news, press releases, and resources about Servier and everything our company has to offer.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
06.16.2021Servier Announces Promising Phase 1 Data for Vorasidenib in IDH Mutant Low-Grade Glioma Published in Clinical Cancer Research-
06.07.2021Servier Presents Updated Translational Data from Perioperative Study of Vorasidenib and TIBSOVO® (ivosidenib tablets) in Patients with IDH Mutant Low-Grade Glioma at ASCO 2021
-
06.01.2021Servier Highlights Novel Approaches to Treating Cancer at the ASCO and EHA 2021 Annual Meetings
-
05.05.2021Servier Announces FDA Filing Acceptance and Priority Review for TIBSOVO® (ivosidenib tablets) in IDH1-mutated Cholangiocarcinoma
-
04.01.2021Servier Completes Acquisition of Agios Pharmaceuticals' Oncology Business
Media Contacts
Servier Media Relations
us2mediarelations@servier.com